Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

ALK inhibitor shows high response rate in patients with advanced NSCLC harboring a specific gene alteration

Prof Yung-Jue Bang - Seoul National University College of Medicine, Seoul, Korea
ALK inhibitor shows high response rate in patients with advanced NSCLC harboring a specific gene alteration ( Prof Yung-Jue Bang - Seoul National University College of Medicine, Seoul, Korea )
11 Jun 2010

New agent, eribulin, derived from marine sponge, increases survival among women with metastatic breast cancer

Prof Christopher Twelves - Leeds Institute of Molecular Medicine and St. James's Institute of Oncology, Leeds, UK
New agent, eribulin, derived from marine sponge, increases survival among women with metastatic breast cancer ( Prof Christopher Twelves - Leeds Institute of Molecular Medicine and St. James's Institute of Oncology, Leeds, UK )
11 Jun 2010

Antibody drug ipilimumab improves long-term survival in previously treated advanced melanoma

Dr Steven O'Day - The Angeles Clinic and Research Institute, Santa Monica, California
Antibody drug ipilimumab improves long-term survival in previously treated advanced melanoma ( Dr Steven O'Day - The Angeles Clinic and Research Institute, Santa Monica, California )
11 Jun 2010

The role of genetic mutations in lung cancer

Prof Fred Hirsch - University of Colorado, Denver
The role of genetic mutations in lung cancer ( Prof Fred Hirsch - University of Colorado, Denver )
8 Jun 2010

The use of monoclonal antibodies to treat mesothelioma

Prof Jan van Meerbeeck - University Hospital, Ghent, Belgium
The use of monoclonal antibodies to treat mesothelioma ( Prof Jan van Meerbeeck - University Hospital, Ghent, Belgium )
8 Jun 2010

Tumour circulating cells

Prof Julien Mazieres - University Hospital, Toulouse
Tumour circulating cells ( Prof Julien Mazieres - University Hospital, Toulouse )
8 Jun 2010

The use of targeted radiotherapy to treat lung cancer

Prof Paul Van Houtte - Institut Jules Bordet, Brussels
The use of targeted radiotherapy to treat lung cancer ( Prof Paul Van Houtte - Institut Jules Bordet, Brussels )
7 Jun 2010

Asbestos related diseases

Prof Nico van Zandwijk - University of Sydney
Asbestos related diseases ( Prof Nico van Zandwijk - University of Sydney )
7 Jun 2010

Personalised treatment for lung cancer

Prof Paul Bunn - University of Colorado, Denver
Personalised treatment for lung cancer ( Prof Paul Bunn - University of Colorado, Denver )
7 Jun 2010

Lung cancer treatment: new drugs and possibilities

Prof Peter Harper - Kings College, London
Lung cancer treatment: new drugs and possibilities ( Prof Peter Harper - Kings College, London )
7 Jun 2010

The future of lung cancer treatment

Prof Pieter Postmus - Vrije Universiteit Medical Centre, Amsterdam
The future of lung cancer treatment ( Prof Pieter Postmus - Vrije Universiteit Medical Centre, Amsterdam )
7 Jun 2010

Advances in the treatment of lung cancer

Prof Rafael Rosell - University of Barcelona
Advances in the treatment of lung cancer ( Prof Rafael Rosell - University of Barcelona )
7 Jun 2010